Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pacritinib in 1q21.3 Amplified Solid Tumors (PAIR)
NCT04520269Phase 2Active, not recruiting
- Sponsor
- National University Hospital
- Start
- Jul 2020
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pacritinib in breast cancer, solid tumor, sponsored by National University Hospital. Started Jul 2020; status: active, not recruiting.
02
Drugs
pacritinib
03
Conditions
breast cancersolid tumor
Beyond the preview
Go deeper on NCT04520269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04520269.